1 / 5

Pain Management Therapeutics Market is Expected to Cross US$ 83 Billion by 2024

The pain management therapeutics market is expected to exceed more than US$ 83 Billion by 2024; Growing at a CAGR of more than 3.5% in the given forecast period.

danishsmith01
Télécharger la présentation

Pain Management Therapeutics Market is Expected to Cross US$ 83 Billion by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pain Management Therapeutics Market is Expected to Cross US$ 83 Billion by2024 Market Research Engine has published a new report titled as “Pain Management Therapeutics Market by Therapeutics Analysis (Antidepressants, Anesthetics, Anticonvulsants, Opioids (Oxycodones, Hydrocodones, Tramadol), Antimigraine Agents, Other Non-narcotic Analgesic); by Indication Analysis (Migraine, Cancer Pain, Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Post- operative Pain) - Global Industry Analysis and Forecast 2016 -2024”. The pain management therapeutics market is expected to exceed more than US$ 83 Billion by 2024; Growing at a CAGR of more than 3.5% in the given forecastperiod. Browse Full Report: https://www.marketresearchengine.com/reportdetails/pain- management-therapeutics-market Pain management is one of the branch of medicine which utilizes an inter punitive approach for improving the superiority and easing the suffering of life of persons who are living with the chronic pain. The usual pain management group consists of clinical psychologists, clinical nurse specialists, physician assistants, occupational therapists, physiotherapists, pharmacists and medical practitioners. Market analyst proposes that almost 20% of world’s population currently suffers from chronic pain. Factors that are increasing number of surgeries, changing lifestyle, increasing geriatric population and increasing prevalence of chronic diseases are responsible for growth in new patients everyyear. The major driving factors of pain management therapeutics market are asfollows: Approving health care reforms and regulatoryscenario Increasing approval of pain management therapeutics between endusers Increasing in geriatric population with high risk of different diseases Growing frequency of chronic paindisorders The restraining factors of pain management therapeutics market are asfollows: Enduring pain relief from medical devices, alternative therapies and surgical procedures Prescription drugexploitation Exclusive rights expiry of entry of generics and keydrugs The pain management therapeutics market is segmented on the lines of its therapeutics, indication and regional. Based on therapeutics segmentation it covers antimigraine agents, non steroidal anti inflammatory drugs, anesthetics, antidepressants, anticonvulsants, opioids and other non narcotic analgesic. Opioidsis further segmented into tramadol, hydrocodones, oxycodaones and others such as methadone, meperidine, fentanyl, codeine, morphine. Based on indication segmentation the pain management therapeuticsmarket

  2. covers cancer pain, post operative pain, migraine, arthritic pain, chronic back pain, fibromyalgia and neuropathic pain. The pain management therapeutics marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries. This reportprovides: An overview of the global market for pain management therapeutics and related technologies. Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through2024. Identifications of new market opportunities and targeted promotional plans forpain management therapeutics. Discussion of research and development, and the demand for new products and new applications. Comprehensive company profiles of major players in theindustry. REPORTSCOPE: The scope of the report includes a detailed study of global and regional markets forpain management therapeutics with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, AstraZeneca, Depomed, Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Limited. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and currentdevelopments. The Pain management therapeutics Markethas been segmented as below: By TherapeuticsAnalysis Antimigraineagents Non steroidal anti inflammatory drugs Anesthetics Antidepressants Anticonvulsants Opioids Tramadol Hydrocodones Oxycodaones Others (Methadone, Meperidine, Fentanyl, Codeine,Morphine)

  3. Other non narcoticanalgesic By IndicationAnalysis Cancerpain Post operativepain Migraine Arthriticpain Chronic backpain Fibromyalgia Neuropathicpain By RegionalAnalysis NorthAmerica Europe Asia-Pacific Rest of theWorld Sample Report: https://www.marketresearchengine.com/reportdetails/pain-management- therapeutics-market • Table ofContents • 1.INTRODUCTION • 2 ResearchMethodology • Global Pain Management Therapeutics Market – IndustryAnalysis • North America Pain Management Therapeutics Market Revenue, (US$ Mn),2014–2024 • Europe Pain Management Therapeutics Market Revenue, (US$ Mn),2014–2024 • Asia Pacific Pain Management Therapeutics Market Revenue, (US$ Mn),2014–2024 • Rest of World Pain Management Therapeutics Market Revenue, (US$ Mn),2014–2024 • CountrySnippet • CompanyProfiles • AbbottLaboratories • AstraZeneca • Depomed,Inc.

  4. Endo Pharmaceuticals,Inc. • GlaxoSmithKlineplc • Johnson &Johnson • MallinckrodtPharmaceuticals • Merck & Co.,Inc. • NovartisAG • Pfizer,Inc. • Purdue PharmaL.P. • Teva Pharmaceutical IndustriesLimited Reasons to Buy thisReport: Obtain the most up to date information available on all pain management therapeutics market globally. Identify growth segments and opportunities in theindustry. Facilitate decision making on the basis of strong historic and forecast of pain management therapeuticsdata. Assess your competitor’s refining portfolio and itsevolution. AboutMarketResearchEngine.com Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop businessstrategies. MediaContact Company Name: Market ResearchEngine Contact Person: JohnBay Email:john@marketresearchengine.com Phone: +1-855-984-1862 Country: UnitedStates

  5. Website:https://www.marketresearchengine.com/

More Related